Healthcare >> CEO Interviews >> November 1, 2002
FREDRIC PRICE was elected Chairman of the Board and Chief
Executive Officer of BioMarin Pharmaceutical Inc. on October 31,
2000. From September 1994 to September 2000 he was President,
Chief Executive Officer, and a member of the Board of Directors
of Applied Microbiology/AMBI, a biotechnology and nutrition
company. From July 1991 to September 1994, he was Vice President,
Finance and Administration and Chief Financial Officer of
Regeneron Pharmaceuticals. From March 1986 to July 1991, he was a
pharmaceuticals and biotechnology industry strategy consultant.
For the 13 previous years, he was employed by Pfizer
Pharmaceuticals where he was a Vice President with both staff and
line responsibilities. Mr. Price received a BA in 1967 from
Dartmouth College and an MBA in 1969 from the Wharton School of
the University of Pennsylvania. He is also a member of the Board
of Directors of LifeSpan BioSciences, Inc., a biotechnology
company based in Seattle, Washington. Profile
TWST: Could you give us a brief overview of what BioMarinPharmaceutical does?
Mr. Price: BioMarin Pharmaceutical is a biotech company that
focuses exclusively on enzyme therapeutics for